Marijuana edibles

Marijuana (cannabis) gummies and edibles. (© AI Visual Vault - stock.adobe.com)

Why So Many Older Adults Are Choosing Cannabis Edibles Over Prescription Drugs

In A Nutshell

  • Older adults are the fastest-growing group of cannabis consumers in the U.S., with many turning to edibles for pain, sleep, and anxiety after running out of other options.
  • Most participants in a new study chose combination THC-CBD products, hoping to get the benefits of both compounds without being locked into just one.
  • Fear of getting high, concerns about drug interactions, and doubts about whether CBD alone actually works were the most common hesitations across all product types.
  • Many older adults are making these decisions with little to no input from their doctors, relying instead on friends, online research, and product marketing.

Older adults in Colorado are quietly showing up at cannabis dispensaries in growing numbers, and they’re not there for the novelty. Their knees hurt. They can’t sleep. They’ve run out of ideas. And increasingly, they’re making these decisions without a word of guidance from their doctors.

A new study published in JAMA Network Open examines a trend reshaping how older adults manage their health. Researchers interviewed 169 adults aged 60 to 85, averaging around 71 years old, who were interested in using cannabis edibles (gummies, chocolates, or capsules) for pain, sleep problems, or mental health concerns like anxiety and depression. Most were women, most were White, and most were highly educated. What emerged is a portrait of a generation quietly self-medicating with a product many clinicians still feel poorly prepared to discuss.

Older adults are now the fastest-growing group of cannabis consumers in the United States. As more states have legalized cannabis, adults in their 60s, 70s, and beyond have increasingly turned to it not for a good time, but for relief. Many appear to be navigating these choices with limited medical guidance, piecing together information from friends, the internet, and product marketing.

Older Adults Turned to Cannabis After Exhausting Other Pain and Sleep Options

For most participants, edible cannabis wasn’t an impulse buy. It was a conclusion reached after a long, frustrating journey through other options. Wanting to avoid pharmaceuticals was the most common reason people decided to try it.

Many participants expressed deep concern about the long-term effects of common medications. One described worrying about anti-inflammatory drugs: “I worry about the side effects of the NSAID meds, the Aleve, Excedrin, aspirin, ibuprofen. They all really do help my arthritis when I take it, but I’ve also had friends that have gotten bleeding ulcers from taking those meds too much. So that’s made me very worried about taking them too often.”

Forty-six participants said they had run out of other options, including prescription drugs, over-the-counter remedies, physical therapy, acupuncture, and massage, and viewed cannabis as a last resort. As one put it: “Only because I’ve gone through so much to try to have the pain taken away. Like with steroid injections, massages, Tramadol, therapy, yoga…”

Thirty-six participants said they were motivated by hearing about benefits from friends, attending medical talks, or reading about cannabis online. A smaller number mentioned wanting a substitute for alcohol or an interest in social or recreational use.

cannabis edibles
Older adults are turning to cannabis edibles for pain and sleep, often without any guidance from their doctors. (Photo by Elsa Olofsson on Unsplash)

Why Most Older Cannabis Users Chose Combination THC-CBD Products

When it came to choosing which type of product to buy, participants faced a genuinely complicated decision. Legal cannabis products generally come in three varieties: those dominated by THC, the compound responsible for the “high” feeling; those dominated by CBD, which does not produce mind-altering effects; and products that combine both.

Nearly 58% of participants chose the combination product. Just under 29% chose CBD-only, and about 14% chose THC-only. This pattern held across all three health concerns: sleep, pain, and mental health.

THC-dominant products attracted participants who believed in their therapeutic potential, but drew significant hesitation due to fears about impairment, increased anxiety, memory effects, or dependency. One participant summarized a worry shared by many: “How high will I get? Will it affect my activities of daily living?”

CBD products were seen as the safer, more socially acceptable option, with no high and no impairment, but the dominant concern was that they might not work. “The only drawback is if it’s ineffective, and it’s just kind of psychosomatic or whatever, like a placebo,” one participant said. Cost was also a deterrent.

Combination products were viewed as a sweet spot, offering the perceived benefits of both compounds without being locked into just one. But that flexibility came with its own frustration. “Well, it would be a little more difficult to figure out which was responsible for whatever I was experiencing. There would be less clarity in what I was doing,” one participant noted. Researchers described this as a “Goldilocks” challenge: participants wanted a ratio that was just right, but had little reliable information to guide them there.

Doctors Are Missing from Older Adults’ Cannabis Decisions

Perhaps the most telling thread running through the study is how rarely physicians appear in participants’ decision-making. Research cited by the authors indicates that many older adults don’t tell their doctors they’re using cannabis, and that doctors themselves often feel ill-equipped to offer guidance on the topic.

Edible cannabis products carry specific risks that are easy to underestimate. Their effects take longer to kick in than other forms, which can lead people to take more than intended. Dosing is uncertain. Because many older adults take multiple medications, researchers flagged possible drug interactions as an important concern. Interviews also took place before participants made purchases, so the study captured expectations and reasoning rather than real-world outcomes.

Older adults are moving forward anyway. They’re in pain, they’re exhausted, and the medical system hasn’t given them better options or better information. Researchers concluded that healthcare providers need to be better prepared for honest conversations with older patients about cannabis, not to discourage them, but to help them make informed choices.


Disclaimer: This article is for general informational purposes only and is not intended as medical advice. Older adults should speak with a qualified healthcare provider before using cannabis, particularly if they take prescription medications.


Paper Notes

Limitations

Several important limitations apply. Participants were largely White, highly educated, and recruited from a limited geographic area within Colorado, a state where recreational cannabis is legal. Findings may not reflect the experiences of more racially and economically diverse older adults, or those in states where cannabis remains illegal. Because the focus was exclusively on edible products, participants’ views on inhaled or topical cannabis were not captured. Participants also varied in prior cannabis experience, which could have shaped their expectations. Finally, the study only included people already interested in using cannabis for pain, sleep, or mental health concerns, and interviews took place before product purchase, so the researchers did not assess whether the products ultimately helped.

Funding and Disclosures

This study was supported by the National Institute on Aging of the National Institutes of Health under award number R01AG066698, with principal investigator Angela Bryan. Dr. Rebecca K. Delaney’s research effort was supported by a K12 Award through the Utah Clinical & Translational Science Institute and the American Heart Association’s 2nd Century Early Career Faculty Independence Award. Isabelle Hong and Nehal K. Bakshi’s efforts were supported by the University of Utah Office of Undergraduate Research. Dr. Angela Bryan disclosed receiving grants from the National Institutes of Health during the study, as well as personal fees from Charlotte’s Web, LLC for service on a Scientific Advisory Board, described as outside the scope of this study. Isabelle Hong disclosed current employment with Epic Systems, though she was not employed there during the active analysis period. No other disclosures were reported.

Publication Details

Title: Edible Cannabis and Pain, Sleep, and Mental Health Management in Older Adults | Authors: Rebecca K. Delaney, PhD; Melissa H. Watt, PhD; Madeline Stanger, BA; Isabelle Hong, BA; Nehal K. Bakshi, BS; Angela Fagerlin, PhD; Angela Bryan, PhD | Journal: JAMA Network Open, Volume 9, Issue 5 | Published: May 8, 2026 | DOI: 10.1001/jamanetworkopen.2026.11718 | Open Access: Distributed under the terms of the CC-BY License.

About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor

Leave a Comment